Introduction
Retinitis pigmentosa (RP) is the most common form of inherited retinal dystrophy, with a prevalence of about 1:4,000 (1) . The disease consists of a progressive photoreceptor atrophy usually with early loss of peripheral rods and later involvement of central cones. In typical clinical pictures, funduscopy shows a diffused dystrophy of the retinal pigment epithelium (RPE), bone spicule pigment deposits in the midperiphery, optic disc pallor, and retinal vessels narrowing. (12) , degenerative myopia (13) , and central serous chorioretinopathy (14) .
The first EDI-OCT study of retinal dystrophies reports on 2 cases of RP, which showed no evidence of choroidal abnormalities (15) . Subsequently, only a few studies have specifically investigated choroid imaging in RP (16) (17) (18) (19) (20) (21) , reporting an association of the disease with a choroidal thickness (CT) decrease. However, the data concerning a possible correlation of choroidal thinning with the clinical features of the retinal disorder are not homogeneous. In fact, one group reported no correlation between subfoveal CT and visual acuity or retinal thickness (17) , while another study showed an association between a thinner choroid and poorer visual acuity or longer duration of the disease (16) . Another investigation (19) did not compare RP and controls, but within the RP series could not find any relationship between CT and visual acuity or the degree of visual field loss. Adhi et al (18) did not evaluate possible correlation between CT and clinical parameters, while another group reported an association between CT decrease and ET-1 plasma levels (20, 21) .
In the present article, we evaluated CT with EDI-OCT in a large series of patients with RP, taking into consideration the possible association of subfoveal CT with some clinical features of the disease.
Methods

Study population
Thirty-nine patients with RP from 34 independent pedigrees were included in the study. Patients with RP were recruited through the Referring Center for Inherited Retinal Degenerations of the Eye Clinic, Careggi Teaching Hospital, Florence, Italy.
Criteria for RP disease phenotype included typical symptoms (night blindness and/or perception of visual field alterations), fundus appearance (diffuse RPE dystrophy, retinal vessels attenuation), electroretinographic (ERG) abnormalities (reduced or absent scotopic response), visual field loss, and previous detection of pathogenic mutations. Typical bone spicule pigment deposits were present in almost all the patients, but were not considered among the inclusion criteria, leaving the possibility of including some cases sine pigmento in the study. Syndromic RP was not included in the study, with the only exception of Usher syndrome.
The control group consisted of healthy subjects not affected by eye disease who were referred to the Eye Clinic for routine checkups and optical correction.
Subjects with a relevant refractive error (myopia higher than 5 D, hyperopia higher than 3 D, astigmatism higher than 3 D), significant cataract or other media opacities, ocular diseases other than RP, age <15 or >70 years, and previous photorefractive treatment were excluded from the study. Moreover, the patients did not have any significant systemic disease, and none of them had a family history of other inherited retinal or systemic disorders.
The study was approved by the local institutional review boards and adhered to the principles of the Helsinki Declaration.
Ophthalmologic examination
First, a medical and ophthalmologic history was obtained from all the subjects included in the study. Then the patients received a comprehensive ophthalmologic examination including measurement of Snellen visual acuity, evaluation of intraocular pressure with applanation tonometry, biomicroscopy of the anterior segment, and funduscopy after dilation with tropicamide 1% eyedrops.
In patients with RP, standard ERG (Retimax CSO) was performed according to existing International Society for Clinical Electrophysiology of Vision guidelines (22) . In most of the cases, visual field was tested with computer-assisted perimetry (full field 120 points screening and central 30-2 test, Humphrey Field Analyzer, Carl Zeiss Meditec) and in a few cases with Goldmann perimetry due to poor collaboration or low visual acuity.
In all the subjects, spectral-domain (SD)-OCT scans were obtained using Cirrus Spectral Domain OCT (Carl Zeiss Meditec Inc.). The used scan pattern was the HRD Single Line Raster (providing the scan of a single high-resolution line) with the EDI acquisition mode, resulting in detailed choroidal imaging. In the RP group, the acquisition protocol also consisted of a macular cube 512 × 128 scan pattern to measure central retinal thickness. Images with a signal strength ≤9 were excluded. To avoid possible diurnal variation of choroidal features (23), EDI-OCT scans were always obtained during the morning clinics, between 8 AM and 2 PM.
Enhanced depth imaging OCT black/white images were then examined by manually measuring CT using the specific cursor provided by the machine. Choroidal thickness was measured as the vertical distance from the hyperreflective line corresponding to the RPE and the hyperreflective line corresponding to the inner surface of the sclera. Measurements were performed in the subfoveal position and at 1,000 µm nasally and temporally to the fovea, only when the border between choroid and sclera could be clearly detected (Fig. 1) . The images where choroidal borders could not be clearly identified (Fig. 2) were excluded from analysis. We compared 2 groups of eyes (defined vs unclear choroidal borders) using the Student t test with a significance threshold of 0.05 for the following parameters: visual acuity, age, macular thickness in both controls and patients with RP, age at disease onset, duration of the disease, visual field, and ERG responses in the RP group.
The average values of CT in the 3 considered locations (subfoveal, nasal, temporal) of the RP and control groups were compared using the Student t test. The differences were considered significant if p<0.05.
In the RP group, the possible association between subfoveal CT and certain clinical parameters (visual acuity, age, age at disease onset, duration of the disease, macular thickness, visual field loss, ERG) was evaluated by means of linear regression analysis with a statistical threshold level of p<0.05. The time of the first clinical diagnosis made by an ophthalmologist was assumed as the age at onset while the difference between age and age at onset was considered as disease duration. Duration of the disease and visual acuity were registered during the ophthalmologic examination and macular thickness was obtained by the OCT Macular Cube scan. Visual field severity grading was obtained, distinguishing for each eye 3 levels of visual field deterioration: mild-moderate peripheral visual field constriction (stage 1), paracentral loss (stage 2), and severe visual field defect with survival of a central isle of vision (tunnel visual field, stage 3). Scotopic ERG responses were classified in 3 progressive stages: amplitude reduction lower than 50% of our laboratory reference normal responses (stage 1), response still detectable but amplitude reduction higher than 50% of the reference values (stage 2), flat ERG response (stage 3).
Optical coherence tomography and visual field evaluation was always performed by 3 experienced operators who shared all the procedures. For CT measurement, the average value was considered for statistical analysis, while for qualitative OCT evaluation (possibility of identifying choroidal borders) and visual field loss classification, the opinion of the senior observer was considered should there be disagreement between the operators.
Results
The study recruited 39 patients with RP (21 female and 18 male) with an average age of 43.3 ± 11.3 years. Twentyeight patients had nonsyndromic RP while 11 patients had Usher syndrome. Twenty-nine patients were unrelated while 10 patients originated from the same family (3 couples consisted of brother and sister, 1 of 2 sisters, and 1 of 2 brothers). The inheritance pattern was autosomal recessive in 23 patients, autosomal dominant in 10 patients, and X-linked in 6 patients. In all the cases, the clinical diagnosis was always confirmed by the detection of pathogenic sequence variants in RP-associated genes. The mutations spectrum of our patients with RP is outlined in Table I . Out of the 78 considered OCT scans, we could reliably detect the choroidal borders in 53 eyes (67.9%), while the remaining 25 scans (32.1%) where choroidal limits were ill-defined were excluded from the study.
In the control group, 73 healthy subjects were included in the study, 39 female and 34 male, with an average age of 42.9 ± 12.10 years. Mean central macular thickness was 263.33 ± 18.5 μm. Out of the 146 OCT scans carried out, 96 images (65.8%) could be reliably evaluated and were considered for analysis, while the remaining 50 (34.2%) were no longer taken into consideration.
Regarding all the considered demographic and clinical parameters, the eyes with unclear choroidal borders (then excluded from further analysis) did not show statistically significant differences in comparison to the eyes with a welldefined choroidal profile.
In the RP group, the mean subfoveal CT was 194.622 ± 71.371 µm, while the mean CT at 1,000 µm from the fovea was 163.207 ± 67.266 µm nasally and 197.056 ± 62.857 µm temporally.
The mean subfoveal CT of the control group was 281.520 ± 74.399 µm, while the mean CT at 1,000 µm from the fovea was 247.593 ± 73.942 µm nasally and 279.458 ± 72.599 µm temporally.
The average CT was always significantly thinner in the RP group compared to the controls (p<0.0001) for all the considered retinal positions (Tab. II) (Fig. 3) .
In the RP group, we could not find any significant association between CT and the considered clinical parameters even if there was a trend for decreasing CT with increasing age (r = -0.23, p = 0.09). In the control group, subfoveal CT showed a slightly significant correlation with age (r = -0.21, p = 0.04) but not with macular thickness or visual acuity.
Discussion
Choroidal thickness was evaluated in a relatively large group of patients with RP in comparison with an age-and sexmatched control group.
Reliable identification of choroidal borders was possible in the majority of the eyes (about 65% of the images) with similar rates in the RP and control groups. These data are in agreement with those of a previous investigation (24) , which reported the ability to reliably visualize the choroid sclera junction in 74% of the eyes using Cirrus OCT. They confirm the value of an EDI-OCT approach in the evaluation of CT The study groups consist of 28 nonsyndromic RP and 11 Usher syndrome (associated with MYO7A and USH2A mutations).
but also highlight the present limits of the technique, which cannot reliably image the choroid in all the examined eyes. This limit probably is not related to the Cirrus OCT machine or the manual measurement procedure that we used for our investigation, as previous papers showed good repeatability and reproducibility of manual CT measurements from images acquired using Cirrus and other OCT instruments (25) (26) (27) (28) (29) .
Hopefully choroidal imaging may be improved by the current availability of new technology, such as swept-source OCT, which uses an innovative light source that provides better penetration of the sampling beam into the ocular tissues (11) . In our series, average CT was always significantly thinner in the RP group in comparison with the controls, for all the considered positions. These findings are in agreement with previous investigations in smaller series of patients affected by RP (16) (17) (18) (19) (20) (21) and with previous reports showing blood flow reduction in RP (4) (5) (6) (7) (8) .
The role of hemodynamic impairment in RP is controversial. According to some authors, blood flow reduction may be due to photoreceptor atrophy induced by the different genetic abnormalities associated with the disease. The photoreceptor loss would determine a decreased oxygen need with consequent reduced blood supply (30, 31) . On the other hand, vascular dysfunction may be a primary factor in the development of the disease. Notably, RP has been associated with subclinical inflammatory processes (32, 33) and an imbalance in the oxidant-antioxidant status (34) , and some authors (35) suggest that these alterations may trigger the production of high levels of ET-1 (21) with consequent vascular dysregulation.
Another possible hypothesis explaining choroidal thinning in RP is the trophic role of the RPE, which supports proper choroidal function probably by means of the secretion of growth factors (36) (37) (38) . Therefore, in RP, retinal degeneration may stimulate choroidal atrophy and conversely choroidal changes may worsen the atrophy of the outer retina.
In our study, in both RP patients and controls, CT showed a slight association with age. A progressive choroidal thinning with age has already been reported in healthy subjects (10, 39) , while a reduction of CT in patients with a longer duration of the disease has been reported in another RP study (16) . In our series, the comparable CT reduction with age in both cases and controls suggests that age may have greater influence on CT decrease than RP progression itself.
The lack of association between CT and disease duration in our RP series may be partially due to the definition of the age at onset; that is, the time of the first diagnosis made by an ophthalmologist. We are aware that this is a very strict criterion, which may influence the results and represent a limitation of our work. In our series (in agreement with everyday clinical practice), the patients were very often unable to report accurately the time of onset of their visual symptoms, so we preferred to choose the moment of the diagnosis as a measurable and unquestionable parameter for statistical evaluation.
In patients with RP, CT was not significantly associated with the other clinical parameters taken into consideration. The lack of an association with visual acuity has already been reported (17, 19) and it may be due to the difficult detection of choroidal borders in some patients (with their exclusion from statistical evaluation) or to the possible persistence in RP of relatively good central vision even in very advanced stages of the disease.
We confirm that CT is reduced in RP. In our patients, choroidal thinning was related only to age and duration of the disease, but not to the other clinical parameters.
Although the clinical implications of choroidal changes in RP have not yet been clearly determined, the evaluation of choroidal features may provide significant information that could be useful to clarify the pathophysiology of the disease. Longitudinal studies may offer additional data to evaluate the progression of choroidal thinning over time in patients with RP.
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